Cervical cancer remains one of the leading causes of cancer-related illness among women worldwide, despite being largely preventable through early screening and vaccination. Human Papillomavirus (HPV) vaccination has emerged as an effective strategy in reducing the risk of cervical cancer by protecting against high-risk HPV strains responsible for most cases of the disease. This case study aimed to examine the effectiveness of HPV vaccination in lowering cervical cancer risk and to explore awareness, perception, and acceptance of the vaccine among women. The study was conducted using a descriptive case study approach involving participants from a selected community healthcare setting. Data were collected through interviews and structured questionnaires focusing on vaccination status, knowledge regarding HPV infection, awareness about cervical cancer prevention, and attitudes toward vaccination. The findings revealed that participants who had received the HPV vaccine demonstrated better awareness regarding cervical cancer prevention and showed a reduced level of concern about HPV-related complications. In contrast, limited knowledge, fear of side effects, social misconceptions, and lack of accessibility were identified as common barriers among unvaccinated individuals. The study highlights the significant role of HPV vaccination in preventing cervical cancer and emphasizes the importance of improving public awareness through educational programs and healthcare campaigns. Increased accessibility to vaccination services and accurate health information can encourage greater vaccine acceptance and contribute to reducing the global burden of cervical cancer. The findings support the need for continued public health efforts to promote HPV immunization, particularly among adolescents and young women.

Keywords:HPV vaccination, cervical cancer, cancer prevention, women’s health, public awareness

🔒 This is a subscription article

Full text is available to subscribers and institutional members. Please choose an option below to access it.

1. World Health Organization. Cervical cancer fact sheet. Geneva: World Health Organization; 2025. Available from: https://www.who.int/news-room/fact-sheets/detail/cervical-cancer.
2. World Health Organization. Immunizing against HPV. Geneva: World Health Organization; 2024. Available from: https://www.who.int/activities/immunizing-against-hpv.
3. Sankaranarayanan R. HPV vaccination: The most pragmatic cervical cancer primary prevention strategy. Int J Gynaecol Obstet. 2015 Oct;131 Suppl 1:S33-5. doi: 10.1016/j.ijgo.2015.02.014. Epub 2015 Feb 25. PMID: 26433502.
4. World Health Organization. Human papillomavirus vaccines (HPV). Geneva: World Health Organization; 2023. Available from: WHO HPV Vaccines Information.
5. Arbyn M, Xu L, Simoens C, Martin-Hirsch PP. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors. Cochrane Database Syst Rev. 2018 May 9;5(5):CD009069. doi: 1002/14651858.CD009069.pub3. PMID: 29740819; PMCID: PMC6494566.
6. Schiffman M, Castle PE. The promise of global cervical-cancer prevention. N Engl J Med. 2005 Nov 17;353(20):2101–4. doi: 1056/NEJMp058171. PMID: 16291978.
7. Bruni L, Albero G, Serrano B, et al. ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in Congo. Summary Report. 2021 Oct 22.
8. Centers for Disease Control and Prevention. HPV vaccination recommendations. Atlanta: CDC; 2024. Available from: https://www.cdc.gov/hpv/hcp/vaccination-considerations/index.html.
9. DeSieghardt A, Ding L, Ermel A, Franco EL, Dagnall C, Brown DR, et al. Population-level effectiveness and herd protection 17 years after HPV vaccine introduction. JAMA Pediatr. 2025 Dec 1;179(12):1326–1334. doi: 1001/jamapediatrics.2025.3568. PMID: 41021257; PMCID: PMC12481364.
10. The Guardian. India trains thousands of medics to promote vaccine in huge push to end cervical cancer. The Guardian. 2025. Available from: The Guardian HPV Vaccine Article.
11. Times of India. Govt launches vaccination drive against cervical cancer. Times of India. 2025. Available from: TOI Cervical Cancer Vaccination Drive.
12. Stelzle D, Tanaka LF, Lee KK, Ibrahim Khalil A, Baussano I, Shah ASV, et al. Estimates of the global burden of cervical cancer associated with HIV. Lancet Glob Health. 2021 Feb;9(2):e161-e169. doi: 10.1016/S2214-109X(20)30459-9. Epub 2020 Nov 16. Erratum in: Lancet Glob Health. 2021 Feb;9(2):e119. doi: 10.1016/S2214-109X(20)30509-X. PMID:33212031; PMCID:PMC7815633.
13. Guida F, Kidman R, Ferlay J, Schüz J, Soerjomataram I, Kithaka B, et al. Global and regional estimates of orphans attributed to maternal cancer mortality in 2020. Nat Med. 2022 Dec;28(12):2563–2572. doi: 1038/s41591-022-02109-2. Epub 2022 Nov 20. PMID: 36404355; PMCID: PMC9676732.
14. Wang W, Sawleshwarkar S, Piraveenan M. Computational approaches of modelling human papillomavirus transmission and prevention strategies: A systematic review. 2024. Available from: ArXiv HPV Prevention Review
15. Bitsouni V, et al. From primary HPV infection to carcinoma in situ: A mathematical approach of cervical intraepithelial neoplasia. arXiv:2403.13302v1 [q-bio.QM] 20 Mar 2024. Available from: https://arxiv.org/pdf/2403.13302.

Cervical cancer remains one of the leading causes of cancer-related illness among women worldwide, despite being largely preventable through early screening and vaccination. Human Papillomavirus (HPV) vaccination has emerged as an effective strategy in reducing the risk of cervical cancer by protecting against high-risk HPV strains responsible for most cases of the disease. This case study aimed to examine the effectiveness of HPV vaccination in lowering cervical cancer risk and to explore awareness, perception, and acceptance of the vaccine among women. The study was conducted using a descriptive case study approach involving participants from a selected community healthcare setting. Data were collected through interviews and structured questionnaires focusing on vaccination status, knowledge regarding HPV infection, awareness about cervical cancer prevention, and attitudes toward vaccination. The findings revealed that participants who had received the HPV vaccine demonstrated better awareness regarding cervical cancer prevention and showed a reduced level of concern about HPV-related complications. In contrast, limited knowledge, fear of side effects, social misconceptions, and lack of accessibility were identified as common barriers among unvaccinated individuals. The study highlights the significant role of HPV vaccination in preventing cervical cancer and emphasizes the importance of improving public awareness through educational programs and healthcare campaigns. Increased accessibility to vaccination services and accurate health information can encourage greater vaccine acceptance and contribute to reducing the global burden of cervical cancer. The findings support the need for continued public health efforts to promote HPV immunization, particularly among adolescents and young women.

Keywords:HPV vaccination, cervical cancer, cancer prevention, women’s health, public awareness

🔒 This is a subscription article

Full text is available to subscribers and institutional members. Please choose an option below to access it.

1. World Health Organization. Cervical cancer fact sheet. Geneva: World Health Organization; 2025. Available from: https://www.who.int/news-room/fact-sheets/detail/cervical-cancer.
2. World Health Organization. Immunizing against HPV. Geneva: World Health Organization; 2024. Available from: https://www.who.int/activities/immunizing-against-hpv.
3. Sankaranarayanan R. HPV vaccination: The most pragmatic cervical cancer primary prevention strategy. Int J Gynaecol Obstet. 2015 Oct;131 Suppl 1:S33-5. doi: 10.1016/j.ijgo.2015.02.014. Epub 2015 Feb 25. PMID: 26433502.
4. World Health Organization. Human papillomavirus vaccines (HPV). Geneva: World Health Organization; 2023. Available from: WHO HPV Vaccines Information.
5. Arbyn M, Xu L, Simoens C, Martin-Hirsch PP. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors. Cochrane Database Syst Rev. 2018 May 9;5(5):CD009069. doi: 1002/14651858.CD009069.pub3. PMID: 29740819; PMCID: PMC6494566.
6. Schiffman M, Castle PE. The promise of global cervical-cancer prevention. N Engl J Med. 2005 Nov 17;353(20):2101–4. doi: 1056/NEJMp058171. PMID: 16291978.
7. Bruni L, Albero G, Serrano B, et al. ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in Congo. Summary Report. 2021 Oct 22.
8. Centers for Disease Control and Prevention. HPV vaccination recommendations. Atlanta: CDC; 2024. Available from: https://www.cdc.gov/hpv/hcp/vaccination-considerations/index.html.
9. DeSieghardt A, Ding L, Ermel A, Franco EL, Dagnall C, Brown DR, et al. Population-level effectiveness and herd protection 17 years after HPV vaccine introduction. JAMA Pediatr. 2025 Dec 1;179(12):1326–1334. doi: 1001/jamapediatrics.2025.3568. PMID: 41021257; PMCID: PMC12481364.
10. The Guardian. India trains thousands of medics to promote vaccine in huge push to end cervical cancer. The Guardian. 2025. Available from: The Guardian HPV Vaccine Article.
11. Times of India. Govt launches vaccination drive against cervical cancer. Times of India. 2025. Available from: TOI Cervical Cancer Vaccination Drive.
12. Stelzle D, Tanaka LF, Lee KK, Ibrahim Khalil A, Baussano I, Shah ASV, et al. Estimates of the global burden of cervical cancer associated with HIV. Lancet Glob Health. 2021 Feb;9(2):e161-e169. doi: 10.1016/S2214-109X(20)30459-9. Epub 2020 Nov 16. Erratum in: Lancet Glob Health. 2021 Feb;9(2):e119. doi: 10.1016/S2214-109X(20)30509-X. PMID:33212031; PMCID:PMC7815633.
13. Guida F, Kidman R, Ferlay J, Schüz J, Soerjomataram I, Kithaka B, et al. Global and regional estimates of orphans attributed to maternal cancer mortality in 2020. Nat Med. 2022 Dec;28(12):2563–2572. doi: 1038/s41591-022-02109-2. Epub 2022 Nov 20. PMID: 36404355; PMCID: PMC9676732.
14. Wang W, Sawleshwarkar S, Piraveenan M. Computational approaches of modelling human papillomavirus transmission and prevention strategies: A systematic review. 2024. Available from: ArXiv HPV Prevention Review
15. Bitsouni V, et al. From primary HPV infection to carcinoma in situ: A mathematical approach of cervical intraepithelial neoplasia. arXiv:2403.13302v1 [q-bio.QM] 20 Mar 2024. Available from: https://arxiv.org/pdf/2403.13302.